Targeted Modifications to Cannabinoids to Propel Entry Into Clinical Trials
- Developing a structured framework for modifying certain parameters of cannabinoids e.g. CBD, to generate new molecules which can be IP protected
- Following criteria framework with well-understood molecules could lead to cannabinoids going into human studies faster than the current rate
- Prioritizing development efforts on different therapeutic areas including epilepsy & obesity